90 related articles for article (PubMed ID: 26855992)
1. [Evaluation of Gene Expression of Hexokinases in Colorectal Cancer with the Use of Bioinformatics Methods].
Krasnov GS; Dmitriev AA; Sadtritdinova AF; Fedorova MS; Snezhkina AV; Melnikova NV; Poteryakhina AV; Nyushko KM; Belyakov MM; Kaprin AD; Zaretsky AR; Kudryavtseva AV
Biofizika; 2015; 60(6):1050-6. PubMed ID: 26855992
[TBL] [Abstract][Full Text] [Related]
2. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
3. [Overexpression of microRNAs miR-9, -98, and -199 Correlates with the Downregulation of HK2 Expression in Colorectal Cancer].
Snezhkina AV; Krasnov GS; Zhikrivetskaya SO; Karpova IY; Fedorova MS; Nyushko KM; Belyakov MM; Gnuchev NV; Sidorov DV; Alekseev BY; Melnikova NV; Kudryavtseva AV
Mol Biol (Mosk); 2018; 52(2):220-230. PubMed ID: 29695690
[TBL] [Abstract][Full Text] [Related]
4. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
5. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
Xu S; Herschman HR
Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Hexokinase 1 as a poor prognosticator in human colorectal cancer.
He X; Lin X; Cai M; Zheng X; Lian L; Fan D; Wu X; Lan P; Wang J
Tumour Biol; 2016 Mar; 37(3):3887-95. PubMed ID: 26476538
[TBL] [Abstract][Full Text] [Related]
7. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition.
Tseng PL; Chen CW; Hu KH; Cheng HC; Lin YH; Tsai WH; Cheng TJ; Wu WH; Yeh CW; Lin CC; Tsai HJ; Chang HC; Chuang JH; Shan YS; Chang WT
Oncotarget; 2018 Apr; 9(27):18949-18969. PubMed ID: 29721175
[TBL] [Abstract][Full Text] [Related]
8. ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion.
Ma X; Chen J; Huang B; Fu S; Qu S; Yu R; Zhao Y
Med Oncol; 2023 Apr; 40(5):154. PubMed ID: 37079118
[TBL] [Abstract][Full Text] [Related]
9. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.
Pudova EA; Kudryavtseva AV; Fedorova MS; Zaretsky AR; Shcherbo DS; Lukyanova EN; Popov AY; Sadritdinova AF; Abramov IS; Kharitonov SL; Krasnov GS; Klimina KM; Koroban NV; Volchenko NN; Nyushko KM; Melnikova NV; Chernichenko MA; Sidorov DV; Alekseev BY; Kiseleva MV; Kaprin AD; Dmitriev AA; Snezhkina AV
BMC Genomics; 2018 Feb; 19(Suppl 3):113. PubMed ID: 29504907
[TBL] [Abstract][Full Text] [Related]
10. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.
Xu S; Catapang A; Braas D; Stiles L; Doh HM; Lee JT; Graeber TG; Damoiseaux R; Shirihai O; Herschman HR
Cancer Metab; 2018; 6():7. PubMed ID: 29988332
[TBL] [Abstract][Full Text] [Related]
11. Hexokinase 2 is targetable for HK1 negative, HK2 positive tumors from a wide variety of tissues of origin.
Xu S; Catapang A; Doh HM; Bayley NA; Lee JT; Braas D; Graeber TG; Herschman HR
J Nucl Med; 2018 Jun; 60(2):212-7. PubMed ID: 29880505
[TBL] [Abstract][Full Text] [Related]
12. High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3.
Cavalcante IP; Zerbini MC; Alencar GA; Mariani Bde P; Buchpiguel CA; Almeida MQ; Mendonca BB; Fragoso MC
Acta Radiol; 2016 Mar; 57(3):370-7. PubMed ID: 25766729
[TBL] [Abstract][Full Text] [Related]
13. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
Patra KC; Wang Q; Bhaskar PT; Miller L; Wang Z; Wheaton W; Chandel N; Laakso M; Muller WJ; Allen EL; Jha AK; Smolen GA; Clasquin MF; Robey B; Hay N
Cancer Cell; 2013 Aug; 24(2):213-228. PubMed ID: 23911236
[TBL] [Abstract][Full Text] [Related]
14. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics.
Garcia SN; Guedes RC; Marques MM
Curr Med Chem; 2019; 26(41):7285-7322. PubMed ID: 30543165
[TBL] [Abstract][Full Text] [Related]
15. Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines.
Rho M; Kim J; Jee CD; Lee YM; Lee HE; Kim MA; Lee HS; Kim WH
Anticancer Res; 2007; 27(1A):251-8. PubMed ID: 17352240
[TBL] [Abstract][Full Text] [Related]
16. An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1
Xu S; Zhou T; Doh HM; Trinh KR; Catapang A; Lee JT; Braas D; Bayley NA; Yamada RE; Vasuthasawat A; Sasine JP; Timmerman JM; Larson SM; Kim Y; MacLeod AR; Morrison SL; Herschman HR
Cancer Res; 2019 May; 79(10):2748-2760. PubMed ID: 30885978
[TBL] [Abstract][Full Text] [Related]
17. Hexokinase 2 regulates G1/S checkpoint through CDK2 in cancer-associated fibroblasts.
Hu JW; Sun P; Zhang DX; Xiong WJ; Mi J
Cell Signal; 2014 Oct; 26(10):2210-6. PubMed ID: 24780297
[TBL] [Abstract][Full Text] [Related]
18. Spermatogenic cell-specific type 1 hexokinase is the predominant hexokinase in sperm.
Nakamura N; Shibata H; O'Brien DA; Mori C; Eddy EM
Mol Reprod Dev; 2008 Apr; 75(4):632-40. PubMed ID: 17924400
[TBL] [Abstract][Full Text] [Related]
19. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.
Palmieri D; Fitzgerald D; Shreeve SM; Hua E; Bronder JL; Weil RJ; Davis S; Stark AM; Merino MJ; Kurek R; Mehdorn HM; Davis G; Steinberg SM; Meltzer PS; Aldape K; Steeg PS
Mol Cancer Res; 2009 Sep; 7(9):1438-45. PubMed ID: 19723875
[TBL] [Abstract][Full Text] [Related]
20. An electrophoretic study of the distribution and properties of human hexokinases.
Rogers PA; Fisher RA; Harris H
Biochem Genet; 1975 Dec; 13(11-12):857-66. PubMed ID: 1239274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]